Pain, Acute

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Pain, Acute is an early-stage landscape with 4 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Preclinical

No programs

Phase 1

No programs

Phase 24

Intravenous Oxytocin

Wake Forest University Health Sciences

Intravenous Placebo

Wake Forest University Health Sciences

Intranasal Oxytocin

University of Electronic Science and Technology of China

Intranasal Placebo

Wake Forest University Health Sciences

Phase 3

No programs

Approved

No programs

Analysis

clinical trials

Not yet recruiting1 · 50%

Completed1 · 50%

Clinical Trials

Not yet recruiting·UUniversity of Utah·Preclinical·NCT07676500·576 enrolled

Completed·WWake Forest University Health Sciences·Phase 2·NCT07053774·24 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)